Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway

Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disorder of the colon, and it has become one of the world-recognized medical problems as it is recurrent and refractory. Berberine (BBR) is an effective drug for UC treatment. However, the underlying mechanism and targets remain obscure....

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Yalan, Fan, Heng, Zhang, Zhe, Jiang, Feng, Li, Mingyue, Zhou, Haifeng, Guo, Weina, Zhang, Zili, Kang, Zhenyu, Gui, Yang, Shou, Zhexing, Li, Junyi, Zhu, Rui, Fu, Yu, Sarapultsev, Alexey, Wang, Huafang, Luo, Shanshan, Zhang, Ge, Hu, Desheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898376/
https://www.ncbi.nlm.nih.gov/pubmed/35280677
http://dx.doi.org/10.7150/ijbs.65476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898376/
https://www.ncbi.nlm.nih.gov/pubmed/35280677
http://dx.doi.org/10.7150/ijbs.65476

Ejemplares similares